Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Revolutions Medical has finalised a manufacturing agreement with Medical Investment Group (MIG).
Subscribe to our email newsletter
MIG, pursuant to the manufacturing agreement with Revolutions Medical, has guaranteed the production and delivery of a minimum of five million 3cc safety syringes per month for a period of five years.
MIG claims that its manufacturing facility is a 250,000sqft factory located on 35 acres in Jiangsu, China and is fully compliant with all FDA and CE/EC requirements and has experience producing and shipping similar medical products for worldwide delivery.
Revolutions Medical CEO Ron Wheet said that securing this first manufacturing relationship and having the ability to produce and ship a minimum of five million safety syringes per month beginning in the first quarter of 2011, they are in a position to sign initial distributors and begin to gauge preliminary sale volumes.
“The facility has the ability to increase production up to 50 million 3cc syringes per month. When we initiate the manufacturing process on our 1cc, 5cc, and 10cc RevVac safety syringes, we will plan to produce those in South Carolina,” Wheet said.